ATTOF (ATTOF) Stock Price & Analysis
ATTOF (ATTOF) rose 0.00% to USD 0 as of June 10, 2026 at 04:03 UTC, according to Nexqual real-time market data.
ATTOF last closed at USD 0; the session ranged USD 0–0 on volume of 200 shares. Market capitalization is $1,460, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:03 UTC.
Key Statistics (as of June 10, 2026 at 04:03 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 200 shares |
| Market Cap | $1,460 |
| Exchange | PNK |
Technical Analysis (ATTOF)
Nexqual's technical model rates ATTOF "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 04:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ATTOF)
Wall Street analysts rate ATTOF "None", per Nexqual as of June 10, 2026 at 04:03 UTC.
| Consensus Rating | None |
|---|
Earnings (ATTOF)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-09-30 | USD 0.08 vs est -0.25 ▲ beat |
| 2022-06-30 | USD -0.25 vs est -0.36 ▲ beat |
| 2022-03-31 | USD 0.31 vs est -0.54 ▲ beat |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financials & Fundamentals (ATTOF)
| Total Revenue | $1.39B |
|---|---|
| Revenue Growth (YoY) | -1.40% |
| Gross Margin | +17.24% |
| Operating Margin | -12.29% |
| Profit Margin | -21.27% |
| Current Ratio | 0.9 |
| Total Cash | $82.93M |
| Total Debt | $743.37M |
| Free Cash Flow | $41.80M |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financial Health Score (ATTOF)
Nexqual rates ATTOF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:03 UTC.
| Growth | Weak — Revenue -4% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 17%, operating -12% |
| Balance Sheet | Mixed — $83M cash vs $743M debt |
| Cash Flow | Mixed — FCF $42M, slim 3.0% margin |
| Efficiency | Mixed — No data |
Ownership (ATTOF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.55% |
| Shares Outstanding | 14.60M |
| Float | 9.45M |
| Short % of Float | +2.16% |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Leadership (ATTOF)
ATTOF is led by Dimitrius Rogerio de Oliveira (age 52), CEO & Director, per Nexqual as of June 10, 2026 at 04:03 UTC.
| CEO & Director | Dimitrius Rogerio de Oliveira (age 52) |
|---|---|
| Chief Financial Officer | Alexandre Mafra Guimarães |
| Director of Investor Relations | Hernan van Waveren |
| Chief Marketing Officer & ESG Director | Pablo Sanchez |
| Managing Director of Atento Colombia | Óscar Velásquez |
Major Backers & Investors (ATTOF)
Notable institutional backers of ATTOF include Farallon Capital Management Llc, Morgan Stanley, Renaissance Technologies, according to Nexqual as of June 10, 2026 at 04:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Farallon Capital Management Llc | 28.87% |
| Morgan Stanley | 0.53% |
| Renaissance Technologies | 0.22% |
| Two Sigma Securities, LLC | 0.18% |
| Goldman Sachs | 0.13% |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBUZ | Bebuzee Inc. | USD 0.02 | ▲ 10.56% |
| KCRD | Kindcard Inc. | USD 0.03 | ▲ 0% |
| TBPMQ | TETRA BIO PHARMA INC | USD 0 | ▲ 0% |
| WOWI | Metro One Telecommunications, I | USD 0 | ▲ 0% |
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▼ 19.23% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:03 UTC. This page is informational and not investment advice.